Whitney Reed, APRN
Nurse Practitioner · Charleston, SCNPI 1073018040
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,088 of the $53,955 with a category attached, or 91.0%. AbbVie accounts for 75.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $24,427 and has fallen 97.0% since, to $722 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $260.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$40K
- Biohaven Pharmaceutical Holding Company Ltd.$12K
- Pfizer$732
- Biohaven Pharmaceuticals, Inc.$173
- Lilly USA, LLC$35
- Averitas Pharma Inc.$32
- plus $14 from 1 others
What the payments were for
- Consulting fees$6751%
- Speaking & faculty fees$49,08891%
- Travel & lodging$1,1022%
- Food & beverage$3,0706%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 137 | $40,469 |
| Biohaven Pharmaceutical Holding Company Ltd. | 52 | $12,500 |
| Pfizer | 5 | $732 |
| Biohaven Pharmaceuticals, Inc. | 9 | $173 |
| Lilly USA, LLC | 2 | $35 |
| Averitas Pharma Inc. | 1 | $32 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$35,488
- NURTEC ODT$12,572
- QULIPTA$9,338
How this compares
$53,955 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 117 | $170,169 |
| Nurtec OdtRimegepant Sulfate | 64 | $88,484 |
| Aimovig AutoinjectorErenumab-Aooe | 108 | $84,564 |
| QuliptaAtogepant | 53 | $65,280 |
| Emgality PenGalcanezumab-Gnlm | 59 | $46,945 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 28 | $30,727 |
| Ajovy SyringeFremanezumab-Vfrm | 13 | $9,143 |
| Sumatriptan Succinate | 98 | $7,041 |
| Zolmitriptan | 15 | $6,178 |
| Naratriptan Hcl | 39 | $2,273 |
| RizatriptanRizatriptan Benzoate | 106 | $1,389 |
| Gabapentin | 127 | $1,104 |
| Duloxetine Hcl | 34 | $855 |
| Topiramate | 96 | $838 |
| Tizanidine Hcl | 66 | $712 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $40,469 | $235,449170 claims |
| PfizerNurtec Odt | $732 | $88,48464 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Charleston
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Kristen LaudatiCharleston$15K
- Alice MazzellaCharleston$12K
- Samantha PecunesCharleston$12K
- Christine BrusmanCharleston$12K
- Shanda HofmannCharleston$11K
- Diane BurdsalCharleston$10K
- Kendall BowlerCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.